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Abstract  26 
The chicken anemia virus is a single-stranded circular DNA virus that encodes 3 genes, 27 
of which the most studied is VP3, also known as Apoptin.  This protein has been 28 
demonstrated to specifically kill transformed cells while leaving normal cells unharmed 29 
in a manner that is independent of p53 status.  Although the mechanistic basis for this 30 
differential activity is unclear, it is evident that the subcellular localization of this protein 31 
is important for this difference.  In normal cells, Apoptin exists in filamentous networks 32 
in the cytoplasm, whereas in transformed cells Apoptin is present in the nucleus and 33 
appears as distinct foci.  We have previously demonstrated that DNA damage signaling 34 
through the ATM pathway induces the translocation of Apoptin from the cytoplasm to 35 
the nucleus where it induces apoptosis. We found that Apoptin contains four checkpoint 36 
kinase consensus sites and that mutation of either threonine 56 or 61 to alanine restricts 37 
Apoptin to the cytoplasm.  Furthermore, treatment of tumor cells expressing Apoptin 38 
with inhibitors of chk1 and chk2 causes Apoptin to localize to the cytoplasm.  39 
Importantly, silencing of Chk2 rescues cancer cells from the cytotoxic effects of Apoptin.  40 
Finally, treatment of virus producing cells with Chk inhibitor protects them from virus-41 
mediated toxicity and reduces the titer of progeny virus.  Taken together, our results 42 
indicate that Apoptin is a sensor of DNA damage signaling, which induces it to migrate 43 
to the nucleus during viral replication. 44 
 45 
 46 
 47 
Importance 48 
The chicken anemia virus (CAV) protein Apoptin is known to induce tumor cell specific 49 
death when expressed.  Therefore, understanding its regulation and mechanism of action 50 
could reveal new insights into tumor cell biology.  We have determined that Checkpoint 51 
kinase 1 and 2 signaling is important for Apoptin regulation and is a likely feature of both 52 
tumor cells and cells producing virus progeny.  Inhibition of Checkpoint signaling 53 
prevents Apoptin toxicity in tumor cells and attenuates CAV viral replication, suggesting 54 
it may be a future target for cancer or anti-viral therapy. 55 
 56 
  57 
  58 
Introduction 59 
Circoviruses are a diverse group of non-enveloped, icosahedral viruses containing 60 
circular, single-stranded DNA genomes (5, 10). These viruses have been shown to infect 61 
a wide range of hosts and are the causative agents of several serious diseases in animals. 62 
In particular, Chicken anemia virus (CAV), a member of the Gyrovirus genus, is the 63 
etiological agent of chicken infectious chicken anemia. CAV infects several bone marrow 64 
derived cells resulting in severe anemia and immunosuppression in young chicks and 65 
compromised immune response in older birds (40, 43). CAV can lead to considerable 66 
economic loss during intensive chicken farming and control of the virus through 67 
vaccination is currently standard practice. Recently, a novel circovirus with partial 68 
homology to CAV isolated from a skin swab was designated human gyrovirus (HGyV) 69 
(39). The identification of HGyV indicates a distinct potential for circovirus human 70 
pathogenesis warranting further investigation.  71 
The negative-sense CAV genome consists of 2,319 nucleotides and is replicated 72 
by a rolling-circle mechanism, although packaging and egress of viral particles is poorly 73 
characterized (5, 36). It encodes multiple overlapping open reading frames (31) that are 74 
translated into three distinct polypeptides.  CAV viral protein 1 (VP1) is the major 75 
structural protein and VP2 is a replicase and has dual-specificity phosphatase activity 76 
(34). VP3, also called Apoptin, is a non-structural protein implicated in the induction of 77 
apoptosis and viral cytotoxicity in host cells. It is currently believed that the induction of 78 
apoptosis by Apoptin by host cell factors represents a late step in the viral replication 79 
cycle, whereby resultant cell death facilitates egress of novel viral particles, perhaps via 80 
association with apoptotic bodies. 81 
Apoptin has attracted considerable interest due to its ability to mediate cell death 82 
selectively in cells that have undergone an oncogenic transformation (14, 17, 25). Pre-83 
clinical in vitro and in vivo proof-of-concept studies performed with Apoptin have 84 
demonstrated some success, with several small animal models showing effective tumor 85 
regression while displaying minimal systemic toxicity (Reviewed in (1)).   86 
Apoptin is a compact, 14kDa polypeptide consisting of 121 amino acids enriched 87 
in basic residues (23). An n-terminal leucine rich sequence (LRS) mediates nuclear 88 
export and multimerization of Apoptin into globular complexes that interact with 89 
multiple cellular partners, notably the promyelocytic leukemia (PML) protein (14, 24). 90 
The C-terminal domain of Apoptin contains both a bipartite nuclear localization sequence 91 
(NLS) and a secondary nuclear export sequence (NES) and together these motifs confer 92 
the nucleocytoplasmic shuttling activity of the protein (8, 14). The extreme C-terminal 93 
residues of Apoptin constitute a functional protein interaction motif mediating interaction 94 
with the anaphase promoting complex or cyclosome (APC/C) ubiquitin E3 ligase. The 95 
APC/C is a 1.5 MDa protein complex that is essential for mitotic progression by 96 
ubiquitinating securin, cyclins and other proteins that prevent mitotic exit (33). 97 
Interestingly, this inhibitory interaction has been shown to mediate p53-independent 98 
G2/M cell cycle arrest and apoptosis in cancer cells by means of APC/C dissociation and 99 
degradation within PML nuclear bodies (PML-NB) (16, 42).  100 
The differential subcellular localization of Apoptin has been implicated as the 101 
major mechanism mediating tumor-specific cytotoxicity (7, 14). In transformed cells, 102 
Apoptin predominantly localizes to the nucleus, whereas this accumulation is impaired in 103 
normal cells. In the host setting of viral replication, CAV induces marked toxicity with 104 
tropism for cells of the hematopoietic lineage (20). These cell types undergo rapid 105 
proliferation and hence are prime candidates for exhibiting replication-associated stress 106 
responses. Stress responses result from the generation of aberrant DNA replication 107 
structures and exposure of the viral single-stranded genome. Similarly, activation of 108 
oncogenes in human cancer promotes deregulated firing of origins of replication, further 109 
contributing to replication stress and facilitating genomic instability (11, 13, 15, 30). 110 
Collectively, these lesions induce a DNA damage response (DDR) mediated by the 111 
phosphatidylinositol 3-kinase-like (PIKK) ataxia telangiectasia mutated (ATM)-Chk2 112 
and ATM-Rad3 related (ATR)-Chk1 kinase axes (6, 26, 45).  113 
Our previous studies have shown that DDR signaling regulates the subcellular 114 
localization of Apoptin requiring both ATM and DNA-dependent protein kinase (DNA-115 
PK) (19).  However, the primary structure of Apoptin lacks consensus motifs for ATM 116 
or DNA-PK (p[Ser/Thr]-Gln) suggesting that a downstream component activated in 117 
response to ATM or DNA-PK could act as a functional Apoptin kinase in human and 118 
avian host cells. In support of this notion, we identified four checkpoint kinase (Chk1 and 119 
Chk2) phosphorylation consensus motifs (Arg-X-X-p[Ser/Thr]) within Apoptin.   120 
In this study, we observed that functional inhibition of Chk1/2 activity was 121 
accompanied by impaired Apoptin nuclear localization and concomitant apoptosis. 122 
Moreover, we demonstrate that Apoptin constitutes a veritable checkpoint kinase 123 
substrate in cancer cells. Two phosphorylation site mutants at the N-terminal domain of 124 
Apoptin (T56A and T61A) show significant impairment in nuclear accumulation, 125 
suggesting that these residues are the principal sites of Chk-mediated phosphorylation.  126 
Importantly, inhibition of the Chk kinases resulted in reduced cytopathic effect in virus 127 
producing cells as well as reduced production of progeny virus.  In summary, the 128 
regulation of Apoptin described in this study provides mechanistic insight necessary for 129 
the establishment of a cohesive model of Apoptin function and contributes to a broader 130 
understanding of dysregulated DNA damage response signaling in human cancer. 131 
 132 
Materials and Methods 133 
Cell lines, viruses and drugs 134 
H1299 non-small cell lung adenocarcinoma were obtained from ATCC and were 135 
maintained in Dulbecco’s Modified Eagle Medium (Wisent Inc, QC, Canada) 136 
supplemented with 10% Fetal Bovine Serum (FBS)(Sigma) and 0.1% gentamycin 137 
(Wisent Inc, QC, Canada) at 37oC with 5% CO2.  MDCC MSB-1 cells (CLS cell lines 138 
services, Eppelheim, Germany), a chicken lymphoblast line immortalized with Marek's 139 
Disease virus, were cultured in 1x RPMI-1640 (Wisent Inc, QC, Canada), supplemented 140 
with 10% FBS and 50ug/mL Gentamycin at 41oC under 5% CO2.  The adenoviruses 141 
encoding Apoptin (Ad-Apwt) or lacZ (Ad-lacZ) were described previously (42) and used 142 
to infect H1299 cells at an MOI of 35.  The CHK1/2 inhibitor AZD7762 was purchased 143 
from Selleck (Houston, TX) and used at the indicated concentrations. 144 
 145 
Site-directed mutagenesis and plasmid construction 146 
Flag-Apoptin point mutants were generated by QuikChange (Stratagene) protocol using 147 
synthetic primers (Sigma) and PCR amplification of a p3XFlag-myc-CMV-26 expression 148 
vector encoding wild-type Apoptin. The N-terminal GFP-Apoptin expression vector was 149 
subcloned from Flag vectors as described in (42). To generate N-terminal hemagluttinin 150 
(HA) tagged Apoptin fusion proteins, wild type and mutant Apoptin open reading frames 151 
were amplified using PCR, digested by restriction endonucleases and ligated into the 152 
pcDNA3-HA vector. Mutant clones were confirmed by sequencing. 153 
 154 
Transfection 155 
H1299 cells were seeded and transfected with indicated plasmids the following day at 156 
70% confluency using Lipofectamine 2000 (InvitrogenTM) following the manufacturer’s 157 
protocol.  Silencing of Chk1 and Chk2 was carried out by overnight transfection of 158 
H1299 cells seeded at low confluency in 6-well plates or 60 mm dishes using 50 nmol of 159 
scrambled siRNA (5’-AAU UCU CCG AAC GUG UCA CGU dTdT-3’), Chk1-1 (5’-160 
GCG UGC CGU AGA CUG UCC AdTdT -3’), Chk1-2 (5’-GCA ACA GUA UUU CGG 161 
UAU A dTdT-3’), Chk2-1 (5’- GAA CCU GAG GAC CAA GAA C dTdT -3’) or Chk2-162 
2 (5’- AAC GCC GUC CUU UGA AUA ACA dTdT-3’) siRNA duplexes (Sigma) and 5 163 
μl Lipofectamine 2000 (InvitrogenTM). Cells were allowed to proliferate for 18 hr prior to 164 
infection with Ad-lacZ or Ad-Apwt. 165 
 166 
Western blotting 167 
SDS-PAGE and western blot were performed with standard protocols using the following 168 
antibodies at the indicated dilutions: 1:1,000 mouse monoclonal anti-Flag M2 (Sigma), 169 
1:1,000 rabbit monoclonal anti-HA (BioLegend), 1:2,000 mouse monoclonal anti-GFP 170 
(Clontech), 1:50 rabbit polyclonal anti-APC1 (described in (42)), 1:1,000 mouse 171 
monoclonal anti-Cdc20 (Santa Cruz), 1:500 mouse monoclonal anti-Cdh1 (NeoMarkers), 172 
1:1,000 (5% BSA) rabbit polyclonal anti-Chk1 (Cell Signaling), 1:500 mouse 173 
monoclonal anti-Chk2 (Santa Cruz), 1:1,000 rabbit polyclonal anti-APC2 (BioLegend), 174 
1:500 mouse monoclonal anti-Cdc27 (BD), 1:1,000 mouse polyclonal anti-APC7 (gift of 175 
AS Turnell), 1:1,000 rabbit polyclonal anti-APC8 (Santa Cruz), 1:1,000 rabbit polyclonal 176 
anti-APC5 (gift of A.S. Turnell.), 1:1,000 rabbit polyclonals against Apoptin and 177 
phospho-Apoptin (T108) have been previously described (18), and 1:1,000 rabbit 178 
polyclonal anti-actin (Sigma).  The secondary antibodies used are 1:5000 goat polyclonal 179 
anti-mouse or mouse anti-rabbit HRP (Jackson ImmunoResearch, Inc.).  The blots were 180 
developed with Western Lightning Plus ECL (PerkinElmer) or SuperSignal West Femto 181 
(Thermo Scientific) chemiluminescent substrates and exposed on film. Secondary 182 
antibodies used for immunofluorescence were Alexa Fluor® 488 and 594-conjugated 183 
goat polyclonal anti-mouse or rabbit (ThermoFisher Scientific). 184 
 185 
Immunofluorescence 186 
Cells grown on glass cover slips or 6-well plates were fixed in ice-cold methanol at −20 187 
°C for 20 min. Cells were washed twice with PBS and blocked in 10% antibody dilution 188 
buffer (ADB: 10% FBS, 0.05% Triton-X 100 in PBS) for 15 min. Staining was carried 189 
out by incubation with primary antibody in 10% ADB for 1 hr at room temperature. Cells 190 
were washed 3 times for 5 min each with PBS, followed by incubation with Alexa 191 
Fluor® conjugated secondary antibodies diluted 1:500 in 10% ADB for 1 hr at room 192 
temperature. Cells were washed again, then counterstained with 4’-6-diamidino-2-193 
phenylindole (DAPI: 1 μg/ml), and mounted on slides using ImmuMount mounting 194 
media (Thermo Scientific ShantonTM). Cells were analyzed using a Zeiss AxioVert 195 
fluorescence microscope with AxioVision and cropped for presentation with ImageJ 196 
software. 197 
 198 
Cell extract preparation 199 
H1299 cells were seeded on 10cm dishes prior to transfection with indicated Flag-200 
Apoptin constructs or infection with adenoviral vectors and treatment with DMSO or 201 
AZD7762. Immunoprecipitation experiments were performed using 1000 μg of whole 202 
cell extract. For whole cell extract preparation, cells were harvested as above and re-203 
suspended in 100 μl of NETN buffer (50mM Tris-Cl pH 7.5, 2mM MgCl2, 150mM NaCl, 204 
1% NP-40) per 1 x 106 cells, vortexed briefly, and lysed on ice for 30 min. Lysates were 205 
then centrifuged at maximum speed for 15 min at 4oC. 4X Laemmli buffer was added to 206 
60 μl of lysate (~200 μg) and set aside as inputs for immunoblot analysis. Supernatants 207 
were incubated with 10 μl of packed EZview red anti-flag M2 affinity gel (Sigma) for 2 208 
hr at 4 °C on an end-over-end rotator. Following incubation, the supernatant was 209 
discarded and beads were washed five times with NETN, eluted in 60 μl 1X Laemmli 210 
buffer, and boiled for 5 min prior to use. Subcellular fractionation was performed as 211 
described previously (19).  All buffers were supplemented with 1 Complete Mini 212 
protease inhibitor cocktail tablet (Roche) per 10 ml.  213 
 214 
Two-dimensional gel electrophoresis 215 
H1299 cells were seeded on 15cm dishes prior to infection with Ad-Apwt and treatment 216 
with DMSO or AZD7762 (6.3 µM). Cells were harvested as above and whole cell 217 
extracts were prepared using 100 µL of modified RIPA buffer (50mM HEPES pH 7.5, 218 
150mM NaCl, 1% Triton-X 100, 0.1% sodium deoxycholate, 0.1% SDS) per 1 x 106 cells 219 
supplemented with protease inhibitors. Flag-Apoptin was purified by 220 
immunoprecipitation as above with washing performed using RIPA buffer. Proteins were 221 
eluted with 60 μl DeStreak rehydration solution (GE) and boiled for 5 min prior to 222 
loading on an Ettan IPGPhor I isoelectric focusing system (Amersham Biosciences) using 223 
pH 6-11 Immobiline DryStrip gels (GE). Gels were rehydrated with DeStreak rehydration 224 
solution in ceramic strip holders overnight prior to isoelectric focusing following the 225 
manufacturer’s recommendation. Gel strips were then incubated sequentially in two 226 
aliquots of equilibration buffer (50mM Tris-Cl pH 8.8, 6M urea, 2% SDS, 30% glycerol) 227 
supplemented with 2% DTT and 2.5% iodoacetamide respectively on a rotating platform 228 
for 15 min each at room temperature. Equilibrated strips were installed into standard 229 
SDS-PAGE cassettes and sealed with 0.5%. Proteins were then resolved in the second 230 
dimension, transferred to nitrocellulose membranes and probed by Flag immunoblotting.  231 
 232 
Flow Cytometry 233 
H1299 cells were seeded at low confluency in 6-well plates or 60mm dishes and 234 
transfected overnight with siRNA duplexes. Cells were then infected with Ad-lacZ or 235 
Ad-Apwt as described above. For cell cycle analysis, cells were trypsinized at 24 hr post-236 
infection, counted, and re-suspended in ice-cold PBS prior to overnight fixation of 1 x 237 
106 cells in 70% ethanol at −20 °C. Cells were subsequently washed and re-suspended in 238 
500 μl of propidium iodide (PI) staining buffer (200 μg/ml PI, 0.5 mg/ml RNase A, 0.1% 239 
Triton-X 100 in PBS) and incubated for 15 min at 37 °C in the dark. For apoptosis 240 
quantification, cells were harvested at 24, 48, or 72 hr post-infection, washed twice, and 241 
re-suspended at 1 x 106 cells/ ml in ice-cold 1X annexin V binding buffer (10mM HEPES 242 
pH 7.4, 140mM NaCl, 2.5mM CaCl2). 100 μl of cell suspension (1 x 105 cells) was 243 
incubated with 5 μl phycoerythrin (PE) conjugated annexin V (BD BioSciences) and 5 μg 244 
7-aminoactinomycin D (7-AAD) (AG Scientific) for 30 min at room temperature in the 245 
dark. Samples were diluted with 400 μl 1x binding buffer prior to data acquisition. The 246 
stained cell preparations were analyzed immediately on a FACSCalibur flow cytometer. 247 
Appropriate unstained and single stained controls were prepared for determination of 248 
compensation using CellQuest Pro software (BD). The data was subsequently processed 249 
with FlowJo software.  250 
 251 
Transfections and preparation of replicative CAV DNA: 252 
Full length CAV replicon used in these studies has been previously described (31).  Viral 253 
genomes were then recircularized with T4 DNA ligase to generate replicative form (RF) 254 
viral genomes. MSB-1 cells were Electroporated using the AMAXA Nucleofector 255 
system, kit T (Lonza) according to the manufacturer's instructions.  2.0 x 106 MSB-1 cells 256 
and 400ng of RF viral DNA were used in each transfection.  Following electroporation, 257 
cells were allowed to recover for one hour before being washed three times in PBS to 258 
eliminate residual RF viral DNA.  The cells were then suspended at 2.5 x 105 cells/mL in 259 
growth media. 260 
  261 
Quantification of viral DNA 262 
Viral DNA was harvested from MSB-1 cells using the QiaAmp Viral RNA Mini kit 263 
(Qiagen) according to manufacturer's instructions.  Purified DNA was then digested with 264 
DpnI to minimize background generated by the bacterially derived RF viral DNA used in 265 
the initial electroporation.  Quantitative polymerase chain reaction (qPCR) amplification 266 
was carried out using the QuantiFast SYBR Green qPCR Kit.  Primers targeting the Vp1 267 
gene were designed such that the product spanned a DpnI restriction site.  Cycling 268 
parameters are as follows:  95oC for 5:00, 95oC for 00:15, 60oC for 00:30, 95oC for 269 
00:15, 60oC for 20:00, Melt curve, 95oC. The primers used to detect the CAV are as 270 
follows:  FW: ATGACCCTGCAAGACATGGG, RV: CTTTTTGCCACCGGTTCTGG 271 
 272 
Statistical analysis 273 
Quantitative data is presented as mean ± standard error of the mean. Where indicated 274 
statistical analyses were performed using the Student’s two-tailed t test with data 275 
collected from 3 or more biological repeats. Significance is displayed in the figures as 276 
follows: * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.0005).  277 
 278 
Results  279 
Chemical inhibition of Chk1/2 induces cytoplasmic accumulation of Apoptin in 280 
tumor cells 281 
Regulation of Apoptin nucleocytoplasmic shuttling by post-translational 282 
modifications, principally phosphorylation, has been proposed to regulate the balance 283 
between NES and NLS activity, maintaining Apoptin in the nucleus of transformed cells. 284 
We previously demonstrated that inhibition of ATM and DNA-PK in H1299 non-small 285 
cell lung adenocarcinoma cells efficiently impaired the nuclear localization of Apoptin 286 
(19). Given that the primary structure of Apoptin lacks ATM or DNA-PK consensus 287 
motifs, we therefore hypothesized that downstream checkpoint kinases, namely Chk1 and 288 
Chk2, could phosphorylate Apoptin and regulate its subcellular localization. In support of 289 
this notion, we identified four Chk consensus motifs within the primary structure of 290 
Apoptin (Arg-X-X-p[Ser/Thr]) at threonine residues 20, 56, 61, and 114.  In order to 291 
assess the involvement of checkpoint kinases in Apoptin localization within transformed 292 
cells, we employed the small molecule ATP-competitive kinase inhibitor, AZD7762, in 293 
H1299 cells expressing Flag-tagged Apoptin.  To examine the effects of AZD7762 on 294 
Apoptin localization, cells were infected and treated with varying concentrations of 295 
AZD7762 or DMSO prior to processing for Flag immunofluorescence. Examination of 296 
the cells revealed mostly cytoplasmic localization of Apoptin in treated cells (Fig1 A).  297 
Quantification of cells revealed a significant dose-dependent increase in cytoplasmic 298 
Apoptin as consistent with observations in representative micrographs (Fig. 1B).  299 
 300 
Silencing of Chk1/2 expression via siRNA induces cytoplasmic accumulation of 301 
Apoptin in tumor cells 302 
In order to determine if Chk1 or Chk2 affect localization of Apoptin we designed 303 
small-interfering RNAs (siRNA) to specifically knock down expression of the kinases. 304 
Immunofluorescence staining of Apoptin showed that specific targeting of Chk1 and 305 
Chk2 alone or in combination resulted in a comparable increase in cytoplasmic 306 
accumulation of Apoptin compared to a non-targeting control sequence (Fig. 2A, C). 307 
Protein levels of Chk1 and Chk2 were analyzed by immunoblotting to verify the 308 
knockdown efficiency (Fig. 2B). Furthermore, combined knockdown using both targeting 309 
sequences did not yield further impairment of nuclear localization. Also, knockdown of 310 
Chk1 and Chk2 with a second set of siRNA duplexes yielded nearly identical results 311 
(data not shown). Thus, Apoptin phosphorylation by individual checkpoint kinases may 312 
represent interdependent events, raising the possibility that Chk1 and Chk2 may regulate 313 
activation of distinct Apoptin functions in a context-dependent manner.  314 
 315 
Apoptin is a checkpoint kinase substrate in cancer cells 316 
To confirm that the regulation of Apoptin subcellular localization by the 317 
checkpoint kinases is a result of phosphorylation, we performed two-dimensional gel 318 
electrophoresis to analyze Flag-tagged Apoptin peptides in the presence or absence of 319 
inhibitor. Flag-Apoptin was introduced by adenoviral infection into H1299 cells with 320 
concurrent treatment with the Chk1/2 inhibitor AZD7762 or DMSO (vehicle control). 321 
Flag-Apoptin was immunoprecipitated under stringent conditions and analyzed in the 322 
first dimension by isoelectric focusing and then by standard SDS-PAGE. The migration 323 
of Apoptin peptides at a greater isoelectric point (pI) can be observed in the presence of 324 
AZD7762 relative to control treatment (Fig. 3A). Since phosphorylated peptides migrate 325 
at a lower isoelectric point, owing to the negative charge of phosphoryl groups at 326 
physiological pH, the compaction of peptides correspond to a distinct loss of 327 
phosphorylation. The migration of Apoptin in the presence of AZD7762 was comparable 328 
to that Flag-Apoptin incubated with lambda phosphatase prior to isoelectric focusing. 329 
These data present, for the first time, evidence suggesting that Chk1 and Chk2 modify the 330 
phosphorylation status of Apoptin in cancer cells.  331 
Previous studies have implicated the phosphorylation of T108 as a critical 332 
mediator of Apoptin localization and function (38). To address whether impairment of 333 
Chk1 and Chk2 alter the phosphorylation status of T108, we isolated Flag-Apoptin 334 
complexes from H1299 cells by immunoprecipitation and performed immunoblot 335 
analysis with a phospho-specific antibody for Apoptin T108. Interestingly, there is a 336 
marked reduction in T108 phosphorylation following treatment with AZD7762 (Fig. 3 337 
B). Moreover, chemical inhibition of Chk1 and Chk2 reproducibly affected the migration 338 
of Flag-Apoptin on SDS-PAGE gels, such that a faster migrating, lower molecular weight 339 
band is clearly visible (Fig. 3B). Our data suggests that inhibition of Chk1 and Chk2 340 
results in cytoplasmic re-localization of Apoptin and loss of phosphorylation at the T108 341 
site by nuclear cyclin-Cdk2 complexes, although we cannot dismiss the possibility that 342 
Chk1 or Chk2 act directly on the non-consensus T108 residue (27). Taken together, our 343 
observations support the hypothesis that Chk-mediated phosphorylation is a regulatory 344 
mechanism of Apoptin activation. 345 
 346 
Mutation of N-terminal threonine residues impairs nuclear localization of Apoptin 347 
in tumor cells.  348 
To determine which of the possible phosphorylation sites might be regulated by 349 
the Chk kinases, we mutated each of the four predicted Chk1/2 phosphorylation sites on 350 
Apoptin to alanines (T20A, T56A, T61A, T114A), transiently transfected the respective 351 
Flag-tagged constructs into H1299 cells and compared their localization pattern with that 352 
of wild-type Apoptin. We observed that the T56A and T61A mutants displayed the 353 
greatest defect in nuclear accumulation, with numerous cells displaying filamentous 354 
Apoptin located in the cytoplasm (Fig. 4A, B). Therefore, our data suggest that 355 
phosphorylation at N-terminal threonine residues facilitate nuclear localization of 356 
Apoptin. Given that the T56A and T61A mutants fail to localize to the nucleus, we 357 
needed to verify that they remain otherwise functional. Therefore, we tested whether the 358 
Apoptin mutants had defects in multimerization activity, which was previously shown to 359 
be essential for induction of apoptosis (14). The aggregation of monomers and 360 
interaction of Apoptin with PML bodies has been shown to require the N-terminal 361 
leucine rich motif (16, 24).  We co-transfected H1299 cells with HA-tagged Apoptin and 362 
mutant Flag-Apoptin and tested the interaction of differentially tagged Apoptin. 363 
Immunoprecipitation of Flag-Apoptin captured both wild type and mutant HA-Apoptin, 364 
indicating that interaction between Apoptin monomers was unaffected (Fig. 4C).  365 
Similarly, we determined if the phosphorylation mutants were still able to interact 366 
with the anaphase-promoting complex. Consistent with previous studies elucidating 367 
extreme C-terminal residues as determinants of APC/C binding (42), wild type Apoptin 368 
was able to pull down both core (APC1, APC2, APC3 or Cdc27, APC5, APC8) and co-369 
activator (Cdc20, Cdh1) components of the complex under the conditions employed in 370 
our assay (Fig. 4D). T56A and T61A mutants immunoprecipitated APC/C subunits with 371 
similar efficiency as wild-type Apoptin, indicating that these mutants are otherwise 372 
functional. Together, these results indicate that residues T56 and T61 are important for 373 
regulating the localization of Apoptin but do not affect other activities of the protein 374 
including multimerization and interaction with the APC/C.  375 
 376 
Chk1/2 activity regulates Apoptin induced G2/M arrest and apoptosis 377 
If checkpoint kinases regulate the subcellular localization of Apoptin, chemical 378 
inhibition or knockdown of Chk1 and Chk2 would be predicted to impair Apoptin 379 
functions in the nucleus. The interaction of Apoptin with the APC/C has been shown to 380 
result in the sequestration of the APC/C to PML bodies, resulting in G2/M arrest (42). To 381 
determine whether Chk1 and Chk2 action is required for Apoptin induced cell cycle 382 
arrest, we performed cell cycle analysis of H1299 cells transfected with siRNAs targeting 383 
Chk1 and/or Chk2 and transduced with an Apoptin-expressing vector. Individual or 384 
combined knockdown of Chk1 and Chk2 alone did not alter the cell cycle as evaluated by 385 
control LacZ expressing cell profiles (Fig. 5A). Analysis of cell cycle profiles from 386 
Apoptin expressing cells revealed a highly reproducible decrease in fraction of cells 387 
containing 4n DNA content upon transfection with siRNA targeting Chk2 (Fig. 5B).  388 
We then investigated the kinetics of Apoptin-induced cell death. H1299 cells were 389 
treated as described above for cell cycle analysis and cell death was assessed at various 390 
time points by Annexin V/AAD staining (Fig5C,D). In accordance with previous studies, 391 
(42), at 72 hours post infection approximately 54% of Apoptin cells were apoptotic in 392 
the nonsilencing controls. Notably, we observed a significant decrease in late apoptotic 393 
cells in cells treated with siRNA targeting either Chk1 or Chk2 (Fig 5C,D). These data 394 
show that silencing of Chk1 and Chk2 functionally delays Apoptin induced cell death, 395 
presumably by impaired accumulation of Apoptin in the nucleus, such that it cannot 396 
execute its pro-apoptotic functions.  397 
 398 
Inhibition of Chk kinase activity in CAV infected cells attenuates virus production 399 
and cytopathic effect 400 
Given the importance of the Chk kinases in regulating Apoptin, we asked whether 401 
this regulation plays a role during CAV viral replication. To accomplish this, we used a 402 
chicken lymphoid cell line transformed with Marek’s Disease virus, MSB-1 cells, that 403 
permit CAV replication (12). We first determined if AZD7762 was able to affect the 404 
localization of Apoptin in the context of viral replication. MSB-1 cells were infected with 405 
wild-type CAV and the localization of Apoptin was examined by immunofluorescence 406 
using an anti-Apoptin polyclonal antibody (18). Figure 6A shows that Apoptin localized 407 
to the nucleus of CAV infected cells but that addition of AZD7762 resulted in 408 
cytoplasmic retention of the protein. This experiment confirms that AZD7762 is able to 409 
inhibit chicken Chk1/2 and that inhibition of the Chk kinases can affect localization 410 
during viral replication. CAV is known to induce a potent cytopathic effect (CPE) (31) 411 
and we therefore determined if AZD7762 had an effect on CPE mediated by viral 412 
replication. Figure 6B shows that MSB-1 cells infected with CAV rapidly decrease in 413 
viability following transfection with CAV, while mock infected cells continued to grow 414 
normally. Interestingly, inhibition of Chk kinases with AZD7762 was able to 415 
significantly protect CAV infected cells from death. We next asked whether treatment of 416 
CAV producing cells with the inhibitor would have an effect on viral replication. When 417 
fresh cells were infected with CAV and treated with AZD7762, we observed an almost 418 
60% decrease in virus production in the treated population (Fig 6C).  Taken together, 419 
these data show that Chk kinase signaling affects Apoptin activity during viral infection 420 
and is required for effective CAV replication. 421 
 422 
Discussion 423 
Subcellular localization has been implicated as the main characteristic 424 
contributing to the selective mechanism of action of Apoptin (7, 14). Although the 425 
importance of Apoptin localization in apoptosis has been well characterized, the 426 
mechanism of regulation and how it relates to viral replication has yet to be addressed. In 427 
the current study we show that chemical inhibition or RNAi-mediated silencing of Chk1 428 
and Chk2 abrogates nuclear accumulation of Apoptin in transformed cells. Consistent 429 
with localization data, we demonstrated that cell cycle arrest and apoptosis induced by 430 
Apoptin is impaired in cells with Chk1 and Chk2 knockdown. Our data shows that two 431 
threonine residues (T56 and T61) adjacent the N-terminal NES motif are sites of Chk 432 
phosphorylation, providing a mechanistic basis for regulation of Apoptin localization. 433 
Importantly, we show that inhibition of Chk1/2-mediated Apoptin phosphorylation and 434 
nuclear localization impairs viral replication.  435 
Although the subcellular localization of Apoptin appears to be a major 436 
mechanism of regulation, there is evidence that other factors may also be required. For 437 
example, it has been demonstrated that forced localization of Apoptin to the nucleus of 438 
primary cells by fusing a canonical nuclear localization signal is insufficient to induce 439 
apoptosis (8, 14). Previous studies have shown that threonine-108 on Apoptin is 440 
phosphorylated in transformed cells and that this modification is important in regulating 441 
apoptotic activity (22, 38). T-108 does not have the consensus of a Chk1/2 target and 442 
others have suggested that it may be targeted by a nuclear kinase such as HIPK2 (35).  443 
Full activation of Apoptin may therefore require a 2-step process whereby DDR signaling 444 
promotes nuclear localization and a nuclear kinase such as HIPK2 then phosphorylates T-445 
108. Consistent with this model, we observe that T-108 phosphorylation is reduced in 446 
cells treated with Chk inhibitors (Fig 3B). Once Apoptin becomes localized to the 447 
nucleus, additional modifications such as sumoylation may also contribute to full 448 
functional activation of the protein (16).      449 
The notion that Chk1 and Chk2 phosphorylation may regulate Apoptin function 450 
by altering localization may explain the transformation specific localization of the 451 
protein. Cancer cells have been shown to have elevated basal levels of DDR signaling 452 
and therefore also have elevated Chk kinase activity (2, 9, 11). In the context of viral 453 
infection, the insights into selective activation of Apoptin presented in our study may aid 454 
in the clarification of Apoptin function in viral replication and pathogenesis. It is likely 455 
that during early stages of viral infection in normal (non-transformed) host cells, Apoptin 456 
remains cytoplasmic and inactive. During rolling-circle replication of the CAV genome, 457 
single-stranded DNA is generated and serves as a trigger for DNA damage sensors, 458 
including RPA and other components involved in ATR activation (40). Abnormal 459 
replication fork structures subsequently generate double-strand break (DSB) and induce 460 
recruitment and activation of ATM (6, 45). In response to signaling events emanating 461 
from these foci, Chk1 and Chk2 subsequently initiate activity on downstream substrates 462 
mediating appropriate repair responses. The abundance of Apoptin and activated Chk1 463 
and Chk2 would steadily increase upon the onset of viral DNA replication, eventually 464 
reaching a threshold analogous to that of transformed cells whereby Apoptin-induced cell 465 
death is initiated. This model is consistent with evidence indicating that nuclear Apoptin 466 
is associated with productive CAV replication and cytopathogenicity (37).  467 
Our group previously characterized an inhibitory consequence of nuclear Apoptin 468 
on DDR focus formation, principally mediated by proteasomal degradation of the 469 
essential DSB mediator, MDC1 (19). It is possible that Apoptin senses ATM-Chk2 and 470 
ATR-Chk1 signaling by direct phosphorylation events, promoting subsequent impairment 471 
of the host response, and thus preventing it from interfering with viral replication. The 472 
inhibitory role of Apoptin is similar in principle to reported functions of several viral 473 
effectors including herpes simplex virus (HSV) immediate early protein ICP0. HSV ICP0 474 
is a functional RING ubiquitin E3 ligase inducing the degradation of RNF8 and RNF168, 475 
which are host factors downstream of MDC1 that facilitate DDR mediator recruitment at 476 
DSB-induced foci (4, 26, 32). Additionally, other DNA viruses including adenovirus, 477 
polyomaviruses, and human papillomavirus encode multiple proteins that regulate the 478 
DDR (3, 29, 44).  479 
 Despite our identification of the mechanistic basis for Apoptin activation by DDR 480 
signaling, the mechanism by which nuclear Apoptin induces apoptosis remain 481 
incompletely defined. Previous work from our group and others has suggested that 482 
interaction with the APC/C results in mitotic catastrophe and cell death (14, 21, 42). 483 
Inhibition of APC/C function is a common mechanism exploited by several metazoan 484 
viruses, presumably to maintain favorable cellular conditions for viral replication (28, 485 
41). Interestingly, in light of essential functions of DDR kinases and mediators in the 486 
coordination of cell cycle checkpoints, the described interplay of Apoptin with the DDR 487 
may represent a strategy common to many viruses. Indeed, understanding the mechanism 488 
of Apoptin may contribute to elucidation of novel links between the DNA damage 489 
response and the spindle assembly checkpoint and virus replication. 490 
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Figure Legends 669 
FIGURE 1. Treatment with pan-Chk inhibitor AZD7762 impairs nuclear localization of 670 
Apoptin in a dose-dependent manner. (A) H1299 cells were infected with Ad-Apwt and 671 
treated with DMSO or indicated concentrations (μM) of AZD7762 (Chk-i). At 24 hr post-672 
infection, cells were processed for Flag immunofluorescence. (B) Quantification of cells 673 
displaying nuclear Apoptin was determined by scoring at least 100 Flag-positive cells per 674 
condition.   675 
 676 
FIGURE 2. RNAi knockdown of Chk1/2 induces cytoplasmic localization of wild-type 677 
Apoptin.  (A) H1299 cells were transfected at low confluency with indicated siRNA 678 
duplexes and allowed to proliferate for 16 hours. Cells were then infected with Ad-Apwt 679 
and processed for Flag immunofluorescence at 24 hr post-infection.  (B) Immunoblot 680 
analysis of the experiment performed in panel A verifying knockdown efficiency and 681 
specificity. (C) Quantification of cells displaying nuclear Apoptin was determined by 682 
scoring at least 100 Flag-positive cells per condition.  683 
 684 
FIGURE 3. Apoptin is a checkpoint kinase substrate in tumour cells. (A) H1299 cells 685 
were infected with Ad-Apwt and treated with DMSO or 6.3 μM AZD7762 (Chk-i). At 24 686 
hr post-infection, Flag-Apoptin was purified by immunoprecipitation under stringent 687 
conditions and resolved in the first dimension with a pH 6-11 gradient and then analyzed 688 
by SDS-PAGE in the second dimension.   Immunoblotting for Flag was performed to 689 
visualize Flag-Apoptin peptides.  Lambda (λ)-phosphatase treatment of purified Flag-690 
Apoptin served as a positive control. (B) H1299 cells were treated with DMSO or 6.3 μM 691 
Chk-i and infected with Ad-Apwt or Ad-lacZ for 24 hr. Whole cell extracts were 692 
prepared for immunoprecipitation of Flag-complexes and immunoblot analysis with the 693 
indicated antibodies (pT108: phospho-specific Ab for phosphorylated Thr108). 694 
 695 
FIGURE 4. Mutation of Thr56 and Thr61 impairs nuclear localization of Apoptin in 696 
H1299 cells. (A) H1299 cells were transfected with Flag-tagged wild type (WT) or 697 
mutant Apoptin.  Cells were allowed to proliferate for 24 hr prior to processing for Flag 698 
immunofluorescence with nuclear staining (DAPI). (B) Quantification of cells displaying 699 
nuclear Apoptin was determined by scoring at least 100 Flag-positive cells per condition. 700 
(C) and (D)  H1299 cells were transfected with the indicated constructs for 24 hr.  Whole 701 
cell extracts were prepared for immunoprecipitation of Flag-complexes and immunoblot 702 
analysis with the indicated antibodies. 703 
 704 
FIGURE 5. RNAi knockdown of Chk2 impairs Apoptin-induced G2/M arrest and 705 
apoptosis. (A) H1299 cells were transfected at low confluency with indicated siRNA 706 
duplexes prior to infection with Ad-Apwt or Ad-lacZ. At 24 hr post-infection (hpi), cells 707 
were fixed and stained with propidium iodide (PI) for flow cytometry. (B) Quantification 708 
of cells containing 4N (G2/M phase) DNA content derived from replicate experiments as 709 
shown in panel A. (C) Representative flow cytometric profiles of cells treated as in panel 710 
A and harvested and stained at 72 hpi with 7-AAD and PE annexin V. PE+, 7-AAD+ 711 
double positive cells corresponding to the late apoptotic population are boxed.  (D) 712 
Quantification of late apoptotic cells at 72 hpi performed by manual gating analysis.   713 
FIGURE 6. Inhibition of Chk kinase activity in CAV producing cells attenuates virus 714 
production and cytopathic effect.  (A) MSB-1 cells were transfected with CAV and 715 
treated with AZD7762 (350 nM) or DMSO. The cells were then fixed and stained for 716 
immunofluorescence as indicated. (B) MSB-1 cells were transfected with CAV and 717 
treated with AZD7762 (350 nM) or DMSO. Cellular viability was monitored over time 718 
by trypan blue staining. (C) MSB-1 cells were transfected with CAV and treated with 719 
AZD7762 (350 nM) or DMSO. Newly synthesized viral genomes were extracted 72 720 
hours post transfection and quantified by quantitative PCR.   721 
 722 
 723 
FIGURE 1. Treatment with pan-Chk inhibitor AZD7762 impairs nuclear localization of Apoptin in a
dose-dependent manner. (A) H1299 cells were infected with Ad-Apwt and treated with DMSO or indicated
concentrations (μM) of AZD7762. At 24 hr post-infection, cells were processed for Flag immunouorescence. 
(B) Quantication of cells displaying nuclear Apoptin was determined by scoring at least 100 Flag-positive 
cells per condition. 
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proliferate for 24 hr prior to processing for Flag immunouorescence with nuclear staining (DAPI). 
(B) Quantication of cells displaying nuclear Apoptin was determined by scoring at least 100 Flag-positive cells 
per condition. (C) and (D)  H1299 cells were transfected with the indicated constructs for 24 hr.  Whole cell 
extracts were prepared for immunoprecipitation of Flag-complexes and immunoblot analysis with the 
indicated antibodies.
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FIGURE 5. RNAi knockdown of Chk2 impairs Apoptin-induced G2/M arrest and apoptosis. (A) H1299 cells were
transfected at low conuency with indicated siRNA duplexes prior to infection with Ad-Apwt or Ad-lacZ. At
24 hr post-infection (hpi), cells were xed and stained with propidium iodide (PI) for ow cytometry.
(B) Quantication of cells containing 4N (G2/M phase) DNA content derived from replicate experments as
shown in panel A.  (C) Representative ow cytometric proles of cells treated as in panel A and harvested and 
stained at 72 hpi with 7-AAD and PE annexin V.   PE+ 7-AAD+ double positive cells corresponding to the late 
apoptotic population are boxed.  (D) Quantication of late apoptotic cells at 72 hpi performed by manual 
gating analysis.   
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FIGURE 6. Inhibition of Chk kinase activity in CAV producing cells attenuates virus production and cytopathic 
eect.  (A) MSB-1 cells were transfected with CAV and treated with AZD7762 (350 nM) or DMSO.  The cells 
were then xed and stained for immunouorescence as indicated.  (B) MSB-1 cells were transfected with 
CAV and treated with AZD7762 (350 nm) or DMSO.  Cellular viability was monitored over time by trypan blue 
staining.  (C) MSB-1 cells were transfected with CAV and treated with AZD7762 (350 nm) or DMSO.  Newly 
synthesized viral genomes were extracted 72 hours post transfection and quantied by quantitative PCR.  
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